mTOR inhibition improves the immunomodulatory properties of human bone marrow mesenchymal stem cells by inducing COX-2 and PGE2
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
mTOR inhibition improves the immunomodulatory properties of human bone marrow mesenchymal stem cells by inducing COX-2 and PGE2
Authors
Keywords
Mesenchymal stem cells, Immunosuppressive properties, Immunogenicity, TSC-mTOR pathway, Rapamycin
Journal
Stem Cell Research & Therapy
Volume 8, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-12-29
DOI
10.1186/s13287-017-0744-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mesenchymal stromal cells and immunomodulation: A gathering of regulatory immune cells
- (2016) Mehdi Najar et al. CYTOTHERAPY
- Rapamycin Augments Immunomodulatory Properties of Bone Marrow-Derived Mesenchymal Stem Cells in Experimental Autoimmune Encephalomyelitis
- (2016) Mansoureh Togha et al. MOLECULAR NEUROBIOLOGY
- Mesenchymal stem cells and immunomodulation: current status and future prospects
- (2016) F Gao et al. Cell Death & Disease
- Phenotypical and Functional Characterization of Bone Marrow Mesenchymal Stem Cells in Patients with Chronic Graft-versus-Host Disease
- (2015) Binsheng Wang et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Enhancement of the immunoregulatory potency of mesenchymal stromal cells by treatment with immunosuppressive drugs
- (2015) John Girdlestone et al. CYTOTHERAPY
- TSC1 Activates TGF-β-Smad2/3 Signaling in Growth Arrest and Epithelial-to-Mesenchymal Transition
- (2015) Antje Thien et al. DEVELOPMENTAL CELL
- Mesenchymal Stromal Cells Disrupt mTOR-Signaling and Aerobic Glycolysis During T-Cell Activation
- (2015) Martin Böttcher et al. STEM CELLS
- Insensitivity of Human iPS Cells-Derived Mesenchymal Stem Cells to Interferon-γ-induced HLA Expression Potentiates Repair Efficiency of Hind Limb Ischemia in Immune Humanized NOD Scid Gamma Mice
- (2015) Yue-Qi Sun et al. STEM CELLS
- Brief Report: The Differential Roles of mTORC1 and mTORC2 in Mesenchymal Stem Cell Differentiation
- (2015) Sally K. Martin et al. STEM CELLS
- Optimization of adipose tissue-derived mesenchymal stem cells by rapamycin in a murine model of acute graft-versus-host disease
- (2015) Kyoung-Woon Kim et al. Stem Cell Research & Therapy
- The bone marrow niche for haematopoietic stem cells
- (2014) Sean J. Morrison et al. NATURE
- Plasticity of mesenchymal stem cells in immunomodulation: pathological and therapeutic implications
- (2014) Ying Wang et al. NATURE IMMUNOLOGY
- Interferon-Gamma Modification of Mesenchymal Stem Cells: Implications of Autologous and Allogeneic Mesenchymal Stem Cell Therapy in Allotransplantation
- (2014) Kisha Nandini Sivanathan et al. Stem Cell Reviews and Reports
- Mechanisms of Immune Modulation by Mesenchymal Stromal Cells and Clinical Translation
- (2013) J. Stagg et al. CURRENT MOLECULAR MEDICINE
- Critical Role of the Tumor Suppressor Tuberous Sclerosis Complex 1 in Dendritic Cell Activation of CD4 T Cells by Promoting MHC Class II Expression via IRF4 and CIITA
- (2013) H. Pan et al. JOURNAL OF IMMUNOLOGY
- TORC1 Suppression Predicts Responsiveness to RAF and MEK Inhibition in BRAF-Mutant Melanoma
- (2013) R. B. Corcoran et al. Science Translational Medicine
- Multipotent stromal cells induce human regulatory T cells through a novel pathway involving skewing of monocytes toward anti-inflammatory macrophages
- (2013) Sara M. Melief et al. STEM CELLS
- Regulation of Immune Responses by mTOR
- (2012) Jonathan D. Powell et al. Annual Review of Immunology
- mTOR Signaling in Growth Control and Disease
- (2012) Mathieu Laplante et al. CELL
- How mesenchymal stem cells interact with tissue immune responses
- (2012) Yufang Shi et al. TRENDS IN IMMUNOLOGY
- Mesenchymal Stem Cells: Mechanisms of Inflammation
- (2011) Nora G. Singer et al. Annual Review of Pathology-Mechanisms of Disease
- Inflammatory conditions affect gene expression and function of human adipose tissue-derived mesenchymal stem cells
- (2010) M. J. Crop et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Prostaglandin E2 plays a key role in the immunosuppressive properties of adipose and bone marrow tissue-derived mesenchymal stromal cells
- (2010) Rosa Yañez et al. EXPERIMENTAL CELL RESEARCH
- Tuberous Sclerosis Complex 2 (TSC2) Regulates Cell Migration and Polarity through Activation of CDC42 and RAC1
- (2010) Yan Larson et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MSCs inhibit monocyte-derived DC maturation and function by selectively interfering with the generation of immature DCs: central role of MSC-derived prostaglandin E2
- (2009) G. M. Spaggiari et al. BLOOD
- mTORC1-Activated S6K1 Phosphorylates Rictor on Threonine 1135 and Regulates mTORC2 Signaling
- (2009) L.-A. Julien et al. MOLECULAR AND CELLULAR BIOLOGY
- Rictor is a novel target of p70 S6 kinase-1
- (2009) C Treins et al. ONCOGENE
- A critical role of IFNγ in priming MSC-mediated suppression of T cell proliferation through up-regulation of B7-H1
- (2008) Huiming Sheng et al. CELL RESEARCH
- Mesenchymal Stem Cell-Mediated Immunosuppression Occurs via Concerted Action of Chemokines and Nitric Oxide
- (2008) Guangwen Ren et al. Cell Stem Cell
- MHC expression kinetics and immunogenicity of mesenchymal stromal cells after short-term IFN-γ challenge
- (2008) Wing Keung Chan et al. EXPERIMENTAL HEMATOLOGY
- The TSC-mTOR Signaling Pathway Regulates the Innate Inflammatory Response
- (2008) Thomas Weichhart et al. IMMUNITY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search